Document is current
Any future updates will be listed below
-
Authors
Nijholt, Kirsten T. https://orcid.org/0000-0002-4979-5698
Meems, Laura M. G.
Ruifrok, Willem P. T.
Maass, Alexander H.
Yurista, Salva R.
Pavez-Giani, Mario G.
Mahmoud, Belend
Wolters, Anouk H. G.
van Veldhuisen, Dirk J.
van Gilst, Wiek H.
Silljé, Herman H. W.
de Boer, Rudolf A.
Westenbrink, B. Daan https://orcid.org/0000-0002-1362-7019
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VENI-016-106-117)
Hartstichting (2007T046, 2019T064)
ZonMw (91111.006)
- License Information
-
More Information
Article History
Received: 1 February 2021
Revised: 16 April 2021
Accepted: 5 May 2021
First Online: 17 June 2021
Declarations
:
: The experimental protocol was accepted by The Animal Ethical Committee of the University of Groningen (DEC4585/IvD 1583–02-011, 1583–02-014). In addition, all animal experiments followed the protocols from Directive 2010/63/EU of the European Parliament.
: Not applicable.
: Not applicable.
: The UMCG, which employs several of the authors, has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Novo Nordisk and Roche. Dr. de Boer received speaker fees from Abbott, AstraZeneca, Novartis and Roche. The other authors do not have any conflict of interest to declare.
